In response to the FDA guidance document for Babesia, CTS will implement the licensed Grifols Babesia test for samples received on April 20, 2020 at the Charlotte, Dallas, Phoenix, St. Louis and Tampa laboratories. Be watching for details on an upcoming webinar that will provide you with an overview of implementing this testing.
Check out the Communication page for the complete details by clicking the link: Communications
CTS communications distributed on July 6th and July 20th.In working with Grifols on the availability...
The CTS Medical Advisory Board recently agreed upon a revision to our standard testing algorithm thi...
After a thorough and comprehensive review of proposals received from suppliers of viral marker testi...
The FDA Guidance ZIKV video for the webinar held on 08/15/18 has been posted in the Wh...
CTS was recently notified that one of the tubes listed in the Sample Acceptability document...
We are informing you that the FDA has announced their withdrawal of Guidance for ZIKV Testing. In th...